Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


UK takes action against PVL-producing strains of Staphylococcus aureus

Lots of work is being done to recognise and control infections such as community acquired MRSA and the UK is learning from situations in community and healthcare settings both here and abroad to stay ahead of the game, scientists will be told today at the Society for General Microbiology’s 162nd meeting being held this week at the Edinburgh International Conference Centre.

Some strains of Staphylococcus aureus produce a potent toxin called Panton-Valentine leukocidin (PVL). PVL-Staphylococcus aureus (PVL-SA) usually causes skin and soft tissue infections, including boils and abcesses. More rarely it can cause serious diseases such as necrotising haemorrhagic pneumonia, which has been associated with a high mortality rate.

“Although several other countries have encountered widespread problems with PVL-related disease, infections caused by PVL S. aureus (including PVL MRSA) remain uncommon in the UK. Nonetheless we need to keep the situation under constant review,” says Dr Angela Kearns from the Health Protection Agency. Tests carried out at the Health Protection Agency’s Staphylococcus Reference Laboratory show that around 2% of all Staphylococcus aureus strains produce the PVL toxin.

“The HPA, working with other healthcare professionals, is in the process of updating guidance on PVL Staphylococcus aureus infection in the UK,” says Dr Kearns. “This will provide healthcare professionals with advice to assist the recognition, investigation and management of PVL-SA cases.”

... more about:
»Healthcare »Kearns »MRSA »PVL »PVL-SA »Staphylococcus »Toxin »aureus

To date, most strains of S. aureus that produce the PVL toxin in the UK have been sensitive to a range of antibiotics, including methicillin. These strains are called methicillin sensitive S. aureus (MSSA). In North America, strains of PVL Staphylococcus aureus, most notably the USA300 clone, have been spreading in the community and are resistant to methicillin. USA300 has become endemic in some US hospitals. In contrast, this strain has rarely been seen in England and Wales: 40 cases were identified during a two year study carried out in 2004/5 and most occurred in the community.

Since 2003, the HPA has actively been encouraging the referral of samples from cases of suspected PVL-related disease. Following these initiatives, 224 PVL-SA infections were identified in England and Wales in 2005; 117 (52%) of these were PVL-MRSA (so-called community-associated MRSA). In 2006, 496 PVL-SA were identified, 159 (32%) of which were PVL-MRSA. These figures show a small (0.4-fold) increase in the number of PVL-MRSA occurring nationally between 2005 and 2006.

“The risk to the UK general public of becoming infected with PVL-S. aureus is small but we must not be complacent,” says Dr Kearns. “The Agency is actively working alongside healthcare colleagues to raise awareness of PVL S. aureus, as well as ensuring appropriate research continues to monitor trends in infection.”

“These PVL strains shouldn’t be confused with the hospital strains of MRSA that do not produce the PVL toxin and are more commonly associated with causing wound infections and blood-poisoning in elderly hospitalised patients,” says Dr Kearns.

“Some of these infections are unavoidable, but we can help to minimise their impact by building on the wealth of knowledge we have from dealing with the hospital adapted strains of MRSA such as employing good hygiene measures which include proper cleansing and disinfection of cuts and minor wounds.”

Lucy Goodchild | EurekAlert!
Further information:

Further reports about: Healthcare Kearns MRSA PVL PVL-SA Staphylococcus Toxin aureus

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>